SOPs for Biosimilars V 2.0

To define the procedure for evaluating the compatibility of cell culture media with biosimilar-producing cell lines during upstream development to ensure optimal growth, productivity, and scalability.
Click to read the full article.

To establish a systematic approach for the detection, investigation, response, and documentation of microbial excursions in upstream biosimilar processes, ensuring GMP compliance and prevention of recurrence.
Click to read the full article.

To define the procedure for safe, compliant, and effective inactivation of used culture broth from biosimilar upstream processes to prevent environmental contamination and ensure biosafety before disposal.
Click to read the full article.

To define the procedure for biosafety-compliant collection, inactivation, segregation, and disposal of culture waste generated during upstream biosimilar manufacturing processes.
Click to read the full article.

To establish a standardized procedure for biosafety monitoring in upstream laboratories handling biosimilar cell cultures to ensure the protection of personnel, containment of biological agents, and compliance with applicable GMP and biosafety regulations.
Click to read the full article.

To define the procedure for documenting, labeling, and verifying all consumables used during bioreactor runs in biosimilar upstream processing, ensuring traceability, quality control, and regulatory compliance.
Click to read the full article.

To establish a uniform procedure for the maintenance of equipment logbooks in biosimilar upstream processing, ensuring proper documentation of usage, cleaning, calibration, and preventive maintenance in compliance with GMP guidelines.
Click to read the full article.

To provide a standardized procedure for safely shutting down a bioreactor in case of an emergency during upstream biosimilar manufacturing, including power failure, equipment malfunction, contamination, or personnel safety threats.
Click to read the full article.

To establish a structured and standardized training procedure for bioreactor operators involved in biosimilar upstream processing to ensure competency, regulatory compliance, and consistent operational performance.
Click to read the full article.

To define a standardized approach for scheduling and executing periodic cleaning of equipment used in biosimilar upstream manufacturing, ensuring control of contamination, compliance with GMP, and maintenance of validated equipment conditions.
Click to read the full article.